Table 2.
Cow Number | Foot Lesions | VNT Titre at Day of Challenge 1 | Duration Virus Detection (Days) | Maximum Titre (log PFU/mL) | Duration Genome Detection (Days) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Serum 2 | Nose 3 | Mouth 4 | Serum 6 | Nose 7 | Mouth 8 | Serum 6 | Nose 7 | Mouth 8 | ||||
Full dose | 1566 | - | 1.2 | 0 | 5 | 6 | 0.0 | 2.7 | 7.7 | 1 | 6 | 8 |
1567 | - | 1.5 | 0 | 3 | 7 | 0.0 | 1.1 | 7.4 | 1 | 7 | 7 | |
1568 | - | 1.2 | 0 | 3 | 4 | 0.0 | 1.9 | 5.2 | 0 | 6 | 7 | |
1569 | - | 1.65 | 0 | 1 | 6 | 0.0 | 0.7 | 8.3 | 1 | 3 | 8 | |
1570 | - | 1.35 | 0 | 1 | 5 | 0.0 | 0.9 | 7.6 | 2 | 4 | 7 | |
1/3 dose | 1571 | - | 1.35 | 0 | 2 | 5 | 0.0 | 0.9 | 8.0 | 1 | 7 | 8 |
1572 | - | 1.05 | 0 | 2 | 5 | 0.0 | 2.6 | 7.9 | 2 | 7 | 8 | |
1573 | - | 1.65 | 0 | 0 | 5 | 0.0 | 0.0 | 5.0 | 0 | 3 | 6 | |
1574 | - | 0.75 | 0 | 2 | 5 | 0.0 | 3.3 | 7.1 | 1 | 5 | 6 | |
1575 | + | 0.6 | 0 | 4 | 7 | 0.0 | 1.0 | 7.1 | 1 | 8 | 8 | |
1/9 dose | 1576 | + | 0.9 | 0 | 2 | 6 | 0.0 | 0.9 | 6.2 | 4 | 6 | 8 |
1577 | - | 1.2 | 0 | 1 | 7 | 0.0 | 0.4 | 7.5 | 2 | 4 | 8 | |
1578 | - | 0.75 | 0 | 3 | 5 | 0.0 | 1.9 | 6.4 | 0 | 4 | 8 | |
1579 | + | 0.3 | 0 | 5 | 5 | 0.0 | 3.2 | 7.0 | 4 | 7 | 8 | |
1580 | + | 0.3 | 0 | 3 | 6 | 0.0 | 3.6 | 7.4 | 4 | 5 | 8 | |
Control | 1581 * | + | <0.3 | 3 | 6 | 7 | 4.8 | 4.7 | 6.7 | 4 | 7 | 7 |
1582 | + | <0.3 | 3 | 6 | 6 | 3.9 | 3.9 | 7.1 | 5 | 8 | 8 | |
1583 | + | <0.3 | 3 | 5 | 7 | 4.7 | 3.7 | 4.9 | 4 | 6 | 8 |
* Cow 1581 died 7 days post challenge. A high concentration of FMD genome was detected in the cardiac muscle and histology revealed infiltration of mononuclear cells and disintegration of muscle tissue. 1 VNT titres at 0 DPC from supplement Table S5b, 2 Serum data from supplement Table S6, 3 Nose swab data from supplement Table S7, 4 Mouth swab data from supplement Table S8.